Immediately after the onset of the Kovid-19 pandemic, anosmia was recognized as a symptomatic feature of the infection.
While the loss of this odor may seem harmless in view of the risks associated with infection with SARS-CoV-2, it can have serious disabilities in people infected with SARS-CoV-2. After recovery, this symptom can last for several weeks or even months.
The Strasbourg team conducted a study on 97 patients with severe anosmia for at least 7 days to determine exactly how quickly patients recover from this feeling.
At 4 months, then at 12 months, they test them to assess their sense of smell.
The result is reassuring: 84.3% of patients recover 96.1% of the odor after 4 months and after 12 months. These observations reveal an “excellent prognosis for related patients”, delighting the authors of this work.
This finding supports the “right of othes that anosmia caused by Kovid-19 infection is associated with peripheral inflammation”. Incentive message to patients.